Global Preventive Asthma Drugs Market By Type of Asthma (Allergic and Non-allergic), By Asthma Trigger Type (Child-onset, Adult-onset, Exercise-induced, Cough-induced, Occupational, Nocturnal, and Steroid-resistant), By Drug class (Bronchodilators, Leukotriene Antagonists, Mast cell Stabilizers, Corticosteroids, and Monoclonal Antibody), By Therapy (Reliever Treatment and Maintenance Treatment), By Route of Administration (Oral, Inhaled, Intravenous, and Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI4018 | Publish Date: December 2023 | No. of Pages: 168

Global Preventive Asthma Drugs Market Overview

Asthma is a common long-term inflammatory disease characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Preventive drugs for asthma play a crucial role in managing the diseases and help pacify the risk of asthma attacks. Asthma attacks are preventable in adults but there is still a rising prevalence of asthma, which is closely linked to severity and mortality of the disease. In particular, this is evident in developed nations.

Global Preventive Asthma Drugs Market Dynamics

Prominent driver of the target market is the high prevalence of the disease owing to rising urbanization and pollution. The need for preventive classes of drugs to keep asthma triggers for patients in check is also boosting growth of the target market. The major restraining factor for the target market is unknown etiology for this condition. Lack of manufacturing facilities, coupled with and high dependence on imports are other key factors hampering growth of the global preventive asthma drugs market in developing economies. Major pharmaceutical companies are investing in their R&D departments for better preventive combination therapies to prevent the disease, which is a key trend in the target market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Preventive Asthma Drugs Market Segmentation

The target market is segmented by type of asthma, asthma trigger type, drug class, therapy, route of administration, and region.

The types of asthma are allergic and non-allergic. The asthma trigger types are child-onset asthma, adult-onset asthma, exercise-induced asthma, cough-induced asthma, occupational asthma, nocturnal asthma, and steroid-resistant asthma (severe asthma). On the basis of drug class, the target market is divided into bronchodilators (beta agonists, anti-cholinergic, xanthines), leukotriene antagonists, mast cell stabilizers, corticosteroids, and monoclonal antibody. Based upon therapy the global market is segmented into reliever treatment and maintenance treatment. On the basis of routes of drug administration the global market can be categorized as  oral, inhaled, intravenous, and subcutaneous.

Global preventive asthma market has been segmented on the basis of region into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa. North America dominates the target market, followed by Europe. Asia Pacific market is expected to witness significant growth during the forecast period owing to increase in incidence of asthma, heightened awareness, and adoption of modern lifestyles.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Global Preventive Asthma Drugs Market Key Players

Key players operating in the global preventive asthma market include GlaxoSmithKline PLC, AstraZeneca PLC, Merck & Company, Inc., Novartis International AG, Boehringer Ingelheim, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc.

Global Preventive Asthma Drugs Market Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Type of Asthma
    • Market Snippet, By Asthma Trigger Type
    • Market Snippet,  By Drug class
    • Market Snippet, By Therapy
    • Market Snippet, By Route of Administration
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Preventive Asthma Drugs Market, By Type of Asthma, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Allergic
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Non-allergic
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Preventive Asthma Drugs Market, By Asthma Trigger Type, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Child-onset
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Adult-onset
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Exercise-induced
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cough-induced
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Occupational
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Nocturnal
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Steroid-resistant
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Preventive Asthma Drugs Market,  By Drug class, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Bronchodilators
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Leukotriene Antagonists
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Mast cell Stabilizers
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Corticosteroids
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Monoclonal Antibody
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Preventive Asthma Drugs Market, By Therapy, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Reliever Treatment
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Maintenance Treatment
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Preventive Asthma Drugs Market, By Route of Administration, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Inhaled
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Intravenous
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Subcutaneous
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Preventive Asthma Drugs Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Asthma Trigger Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Asthma Trigger Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Asthma Trigger Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Asthma Trigger Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Type of Asthma, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Asthma Trigger Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • GlaxoSmithKline PLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca PLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck & Company, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Teva Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sunovion Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

The target market is segmented by type of asthma, asthma trigger type, drug class, therapy, route of administration, and region.

Prominent driver of the target market is the high prevalence of the disease owing to rising urbanization and pollution. The need for preventive classes of drugs to keep asthma triggers for patients in check is also boosting growth of the target market.

Asia Pacific market is expected to witness significant growth during the forecast period owing to increase in incidence of asthma, heightened awareness, and adoption of modern lifestyles.

Key players operating in the global preventive asthma market include GlaxoSmithKline PLC, AstraZeneca PLC, Merck & Company, Inc., Novartis International AG, Boehringer Ingelheim, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc.